West Pharmaceutical Debt
WST Stock | USD 344.00 16.53 5.05% |
West Pharmaceutical holds a debt-to-equity ratio of 0.121. At this time, West Pharmaceutical's Short Term Debt is comparatively stable compared to the past year. Long Term Debt Total is likely to gain to about 209.4 M in 2024, whereas Long Term Debt is likely to drop slightly above 69.2 M in 2024. . West Pharmaceutical's financial risk is the risk to West Pharmaceutical stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
West Pharmaceutical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. West Pharmaceutical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps West Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect West Pharmaceutical's stakeholders.
For most companies, including West Pharmaceutical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for West Pharmaceutical Services, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, West Pharmaceutical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 9.0525 | Book Value 37.96 | Operating Margin 0.2232 | Profit Margin 0.1737 | Return On Assets 0.1 |
West |
West Pharmaceutical Bond Ratings
West Pharmaceutical Services financial ratings play a critical role in determining how much West Pharmaceutical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for West Pharmaceutical's borrowing costs.Piotroski F Score | 7 | Strong | View |
Beneish M Score | (2.80) | Unlikely Manipulator | View |
West Pharmaceutical Debt to Cash Allocation
West Pharmaceutical Services has 309 M in debt with debt to equity (D/E) ratio of 0.12, which may show that the company is not taking advantage of profits from borrowing. West Pharmaceutical has a current ratio of 3.72, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for West to invest in growth at high rates of return.West Pharmaceutical Total Assets Over Time
West Pharmaceutical Assets Financed by Debt
The debt-to-assets ratio shows the degree to which West Pharmaceutical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.West Pharmaceutical Debt Ratio | 5.57 |
West Pharmaceutical Corporate Bonds Issued
West Short Long Term Debt Total
Short Long Term Debt Total |
|
Understaning West Pharmaceutical Use of Financial Leverage
West Pharmaceutical's financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to West Pharmaceutical's current equity. If creditors own a majority of West Pharmaceutical's assets, the company is considered highly leveraged. Understanding the composition and structure of West Pharmaceutical's outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Last Reported | Projected for Next Year | ||
Short and Long Term Debt Total | 309 M | 230.5 M | |
Net Debt | -544.9 M | -517.7 M | |
Short Term Debt | 169.4 M | 177.9 M | |
Long Term Debt | 72.8 M | 69.2 M | |
Long Term Debt Total | 186 M | 209.4 M | |
Short and Long Term Debt | 134 M | 140.7 M | |
Net Debt To EBITDA | (0.64) | (0.61) | |
Debt To Equity | 0.08 | 0.07 | |
Interest Debt Per Share | 3.14 | 2.42 | |
Debt To Assets | 0.06 | 0.06 | |
Long Term Debt To Capitalization | 0.02 | 0.02 | |
Total Debt To Capitalization | 0.07 | 0.07 | |
Debt Equity Ratio | 0.08 | 0.07 | |
Debt Ratio | 0.06 | 0.06 | |
Cash Flow To Debt Ratio | 3.46 | 3.63 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.